Robotic Medial Congruent Vs. Conventional Medial Pivot TKA

NCT ID: NCT06858358

Last Updated: 2025-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-24

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multicenter, prospective cohort study will evaluate whether Robotic-Assisted total knee arthroplasty (RATKA) with a Medial Congruent implant is a successful method to improve implant alignment, insert thickness accuracy, and patient satisfaction, compared to a conventional TKA (cTKA) Medial Pivot technique. It aims to assess and compare clinical and functional outcomes in patients with severe knee osteoarthritis at 3, 6, and 12 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective, non-randomized, multicenter trial evaluates robotic-assisted (ROSA® Robotic Platform with Zimmer Biomet Persona® Medial Congruent) versus conventional (MicroPort Evolution® Medial-Pivot) total knee arthroplasty (TKA) in approximately 300 adults with severe osteoarthritis. By comparing robotic precision with a well-established Medial-Pivot design, this investigation aims to clarify whether robotic-assisted TKA confers superior implant positioning, reduced alignment outliers, and enhanced patient-reported outcomes (PROMS). The primary outcome measures include insert thickness, alignment accuracy (outliers defined as \>2° from the mechanical axis on full-leg radiographs), and patient satisfaction at 6 and 12 months. Two surgeons will perform both techniques, and one surgeon will perform only the conventional procedure. The 18-month study is conducted under local Institutional Review Board approvals (Medlife, Medicover, SCJU Cluj Napoca, Monza Bucuresti) and complies with GDPR. Results are intended for publication in a high-impact orthopedic journal. No external funding is provided.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthristis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ROSA Robotic-assisted TKA with Zimmer Biomet Persona Medial Congruent implant

Group Type EXPERIMENTAL

Robotic assisted total knee arthroplasty

Intervention Type PROCEDURE

• ROSA RATKA with Zimmer Biomet Persona Medial Congruent

Conventional TKA with Microport Evolution Medial-Pivot

Group Type EXPERIMENTAL

Conventional total knee arthroplasty (cTKA)

Intervention Type PROCEDURE

cTKA with Microport Evolution Medial-Pivot

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Robotic assisted total knee arthroplasty

• ROSA RATKA with Zimmer Biomet Persona Medial Congruent

Intervention Type PROCEDURE

Conventional total knee arthroplasty (cTKA)

cTKA with Microport Evolution Medial-Pivot

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with severe osteoarthritis (greater than III Ahlback)

Exclusion Criteria

Patients who refuse participation in the study Low-grade osteoarthritis
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iuliu Hatieganu University of Medicine and Pharmacy

OTHER

Sponsor Role collaborator

County Clinical Emergency Hospital Cluj-Napoca

OTHER

Sponsor Role collaborator

George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marian Andrei Melinte

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MedLife Humanitas Hospital

Cluj-Napoca, Cluj, Romania

Site Status RECRUITING

Medicover Cluj Hospital

Cluj-Napoca, Cluj, Romania

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Romania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marian A Melinte

Role: CONTACT

+40 728 923 062

Razvan M Melinte, MD, PhD

Role: CONTACT

+40 722 331 327

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Razvan M Melinte, MD, PhD

Role: primary

+40 722 331 327

Horea Benea, MD, PhD

Role: primary

+40 724 528 188

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

rosa_MP_MC_3002025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Robotic Assisted TKA
NCT06062615 COMPLETED NA